Primary squamous-cell carcinoma of the thyroid shows an aggressive biological phenotype . . Adenocarcinoma (81403) of the bladder Very rare (2%) and almost impossible to distinguish from primary prostate carcinoma which has extended into the bladder. C and E treatment involves removing the surface of the skin cancer with a scraping instrument (curet) and then searing the base of the cancer with an electric needle. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. by John Verhovshek, MA, CPC The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, Per the 2020 ICD-10 guidelines, 'consistent with' should be treated as an uncertain diagnosis, wh [QUOTE="TThivierge, post: 478222, member: 216725"] Includes Basal Cell, Squamous Cell and Carcinoma In Situ of Skin Background . End Users do not act for or on behalf of the CMS. The page could not be loaded. John Verhovshek, MA, CPC, is a contributing editor at AAPC. The AMA assumes no liability for data contained or not contained herein. icd 10 code for bone marrow edema right knee. If you would like to extend your session, you may select the Continue Button. All neoplasms are classified in this chapter, whether they are functionally active or not. Create your account. End User Point and Click Amendment: apply equally to all claims. Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. No fee schedules, basic unit, relative values or related listings are included in CPT. This email will be sent from you to the Complete absence of all Bill Types indicates MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. C44.02 Squamous cell carcinoma of skin of lip When billing for non-covered services, use the appropriate modifier. You can collapse such groups by clicking on the group header to make navigation easier. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt. 635 0 obj <>stream Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. Contractors may specify Bill Types to help providers identify those Bill Types typically All Rights Reserved. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. "JavaScript" disabled. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Location. Subscribe to Codify by AAPC and get the code details in a flash. Code History. Refer to the LCD for reasonable and necessary requirements and limitations. 604 0 obj <> endobj Revenue Codes are equally subject to this coverage determination. used to report this service. Absence of a Bill Type does not guarantee that the squamous cell carcinoma in situ icd 10: However, please note that once a group is collapsed, the browser Find function will not find codes in that group. C44.42 Squamous cell carcinoma of skin of scalp and neck Margins negative for You are correct - per Paget's, if it's a skin biopsy, it has to be a 305 no matter the size or number of cassettes (I have included the Paget's rule below). In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. preparation of this material, or the analysis of information provided in the material. You can use your browser's Print function (Ctrl-P on a PC or Command-P on a Mac) to view a print preview and then select PDF as the output. Youll find a lot of suggestions and better answers to your question in the Member Forums. All neoplasms are classified in this chapter, whether they are functionally active or not. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. My provider is documenting a squamous cell carcinoma in situ of the jaw, do I code this as C44.329 or D04.39 as the SCC and in situ are separate ICD-10 codes? An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. CMS believes that the Internet is All those not listed under the ICD-10- Codes that Support Medical Necessity section of this article. recipient email address(es) you enter. _, C68. Privacy Policy | Terms & Conditions | Contact Us. There are multiple ways to create a PDF of a document that you are currently viewing. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. This page displays your requested Article. These codes can be used for all HIPAA-covered transactions. Very few histological types are identified in ICD. resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. The CMS.gov Web site currently does not fully support browsers with of the Medicare program. 21767324 DOI: 10.1111/j.1524-4725.2011.02088.x Abstract Background: It should be treated before invasive cancer develops, especially in transplant recipients, who may develop more aggressive skin cancers. Healthcare providers are granted even more latitude for use of telehealth services during the COVID19 public health emergency. article does not apply to that Bill Type. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. The remaining 15% is accounted for by small cell carcinoma. The 4.2 cm excised diameter lesion Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. [/QUOTE] Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). An asterisk (*) indicates a The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. This type of excision would be most appropriately reported using the excision of malignant lesion including margins codes 11600- 11646. All Rights Reserved. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, AMA Plaza 330 N. Wabash Ave., Suite 39300, Chicago, IL 60611-5885. The AMA assumes no liability for data contained or not contained herein. Hi Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. Since the morphology of the lesions can mimic that of other cutaneous disorders, Bowen's disease is often not recognized initially. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom End User License Agreement: Listed below are all Medicare Accepted ICD-10 codes under D04 for Carcinoma in situ of skin. There are different article types: Articles are often related to an LCD, and the relationship can be seen in the "Associated Documents" section of the Article or the LCD. D04.4 would be incorrect as this is documented neither [I]in situ [/I]nor as a carcinoma of the skin. (based on ajcc cancer staging). resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. If the "INDICATOR" is set to "2" these records were re -reviewed and over road the rules from ICD-O-3 code book. C44.12: Squamous cell carcinoma of skin of eyelid, including canthus. Neither the United States Government nor its employees represent that use of such information, product, or processes CPT codes, descriptions and other data only are copyright 2022 American Medical Association. "JavaScript" disabled. Please visit the. B5l2`4'l2_v n6M#~zx#d[mp1VXlu[1NWJu~@}Z~@R'h&\x$f$e" =ih9L|-U*|=LeXOs9"eY9j=IYRh{p "AYqn[sNxD!D>* Hqq0.DzXCX|P| VGi] kb$+%=IpzpTkk*. The submitted CPT/HCPCS code must describe the service performed. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). C44.32- Squamous cell carcinoma of skin of other an unspecified parts of face As a result, in ICD-10, five different categories of four characters each are needed to describe all lung neoplasms (see Figure 2). It begins in the squamous cells, which comprise most of the skins epidermis. Squamous cell carcinoma (SCC) is the second most common type of skin cancer. . Neither the United States Government nor its employees represent that use of such information, product, or processes Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). preparation of this material, or the analysis of information provided in the material. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, Intraepidermal squamous carcinoma of face, Squamous cell carcinoma in situ, skin of face. This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code. will not infringe on privately owned rights. This is the American ICD-10-CM version of C44.91 - other international versions of ICD-10 C44.91 may differ. This Agreement will terminate upon notice if you violate its terms. All rights reserved. C44.13- Sebaccous cell carcinoma of skin of eyelid, including canthus Note: Effective 10/1/2018 . ICD-10 code Z85.828 for Personal history of other malignant neoplasm of skin is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services . Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of breast. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. The views and/or positions As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. required field. Some articles contain a large number of codes. I hope this helps you. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential Federal government websites often end in .gov or .mil. apply equally to all claims. damages arising out of the use of such information, product, or process. On a Friday at monthend theCenters for Medicare 38 Medicaid Services CMS Proton therapy has been a tough sell for payers but recent 25 million Oklahoma decision against Aetna may make them reconsider coverage for the spreading radiation therapy technique. Also, you can decide how often you want to get updates. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. C44.02 Squamous cell carcinoma of skin of lip C44.12- Squamous cell carcinoma of skin of eyelid, including canthus Article document IDs begin with the letter "A" (e.g., A12345). Lady T:cool: [QUOTE="jh1991, post: 469112, member: 237375"] Medicare Telehealth Coding as of April 30, Failure to Approve Proton Tx Costs Aetna $25 M, MIPS Quality Measures Affected by ICD-10 Update. S. Non-small cell lung cancer (NSCLC) accounts for up to 85% of all malignant neoplasms of this localization. Skin []. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. SCCs often occur on the sun-exposed areas of the body, such as the rim of the ear, lower lip, face, bald scalp, neck, hands, arms, and legs. All rights reserved. Squamous cell carcinoma, skin of left breast; Squamous cell carcinoma, skin of right breast; ICD-10-CM C44.521 is grouped within Diagnostic Related Group(s) (MS-DRG v 40.0): 606 Minor skin disorders with mcc; 607 Minor skin disorders without mcc; Convert C44.521 to ICD-9-CM. Popular urban legend Hi, Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). Lady T:cool: The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. Draft articles have document IDs that begin with "DA" (e.g., DA12345). Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with Draft articles have document IDs that begin with "DA" (e.g., DA12345). Squamous cell carcinoma of skin of lip C44.09 . Whether the site is primary, secondary, or carcinoma, Site on the skin (e.g., trunk, upper limb, or lower limb). GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES Please do not use this feature to contact CMS. an effective method to share Articles that Medicare contractors develop. The AMA is a third party beneficiary to this Agreement. All Rights Reserved (or such other date of publication of CPT). In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. We are looking for thought leaders to contribute content to AAPCs Knowledge Center. proven squamous cell carcinoma on his back. The development of SCCis has also been associated with immunosuppression . Federal government websites often end in .gov or .mil. Laser therapy. descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work . Instructions for enabling "JavaScript" can be found here. Stage 0: tis: carcinoma in situ; n0: no regional lymph node metastasis; m0: no distant metastasis. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the If you are looking for a specific code, use your browser's Find function (Ctrl-F) to quickly locate the code in the article. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. Primary malignant neoplasms overlapping site boundaries. The views and/or positions presented in the material do not necessarily represent the views of the AHA. and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only q_r7ds1A"TTD`3i6`q@Jia$D/ %]/_ The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. AHA copyrighted materials including the UB‐04 codes and Objectives: To determine patient and disease characteristics, treatment patterns and long-term outcomes, in order to help direct management of patients with VIN 3, to examine the risk of development of cancer following a diagnosis of VIN 3 and the risk of recurrent disease requiring multiple treatment episodes, and to review patients with vulval cancer, in order to establish the relative . The Table of Neoplasms should be used to identify the correct topography code. M0: no clinical or radiographic evidence of distant metastasis. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable prognosis, yet patients of color and low socioeconomic status (SES) continue to experience inferior outcomes. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33813 - Destruction of Malignant Skin Lesions, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER OVER 4.0 CM, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Merkel cell carcinoma of overlapping sites, Other specified malignant neoplasm of skin of lip, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Malignant neoplasm of peripheral nerves of head, face and neck, Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder, Malignant neoplasm of peripheral nerves of right upper limb, including shoulder, Malignant neoplasm of peripheral nerves of left upper limb, including shoulder, Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip, Malignant neoplasm of peripheral nerves of right lower limb, including hip, Malignant neoplasm of peripheral nerves of left lower limb, including hip, Malignant neoplasm of peripheral nerves of thorax, Malignant neoplasm of peripheral nerves of abdomen, Malignant neoplasm of peripheral nerves of pelvis, Malignant neoplasm of peripheral nerves of trunk, unspecified, Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system, Malignant neoplasm of connective and soft tissue of head, face and neck, Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip, Malignant neoplasm of connective and soft tissue of right lower limb, including hip, Malignant neoplasm of connective and soft tissue of left lower limb, including hip, Malignant neoplasm of connective and soft tissue of thorax, Malignant neoplasm of connective and soft tissue of abdomen, Malignant neoplasm of connective and soft tissue of pelvis, Malignant neoplasm of connective and soft tissue of trunk, unspecified, Malignant neoplasm of overlapping sites of connective and soft tissue, Malignant neoplasm of head, face and neck, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Some older versions have been archived.

Penny, Nickel, Dime Riddle, Prier Pour Quelqu'un Qu'on Aime, Articles I